Rationality of routine clinical use of olokizumab in COVID-19

Routine clinical use of olokizumab in COVID-19 is not recommended. The use of olokizumab is possible in clinical trials.

書誌詳細
出版年:	Качественная клиническая практика
主要な著者:	V. M. Tsvetov, A. V. Matveev, D. A. Sychev
フォーマット:	論文
言語:	ロシア語
出版事項:	Izdatelstvo OKI 2020-10-01
主題:	коронавирус олокизумаб covid-19
オンライン･アクセス:	https://www.clinvest.ru/jour/article/view/530

類似資料

Efficacy and safety of olokizumab in the treatment of rheumatoid arthritis in real clinical practice in Kazakhstan
著者:: G. A. Togizbayev, 等
出版事項: (2020-12-01)

Current and future use of remdesivir in patients with COVID-19
著者:: V. M. Tsvetov, 等
出版事項: (2020-10-01)

Current and future use of dipyridamole in patients with COVID-19
著者:: I. S. Burashnikova, 等
出版事項: (2020-10-01)

Is it possible to use riamilovir to prevent infection and treat COVID-19?
著者:: V. M. Tsvetov, 等
出版事項: (2020-10-01)

Current and future use of umifenovir in patients with COVID-19
著者:: Yu. Yu. Kiselev, 等
出版事項: (2020-10-01)

Possibilities for the use of anakinra in COVID-19
著者:: V. A. Otdelenov, 等
出版事項: (2020-10-01)

Possibilities for the use of tofacitinib in patients with COVID-19
著者:: A. V. Matveev, 等
出版事項: (2020-10-01)

Current and future use of favipiravir in patients with COVID-19
著者:: A. V. Matveev, 等
出版事項: (2020-10-01)

Current and future use of colchicine in patients with COVID-19
著者:: Yu. Yu. Kiselev, 等
出版事項: (2020-10-01)

Possibility to use barycytinib in patients with COVID-19, including for treatment of «cytokine storm»
著者:: V. A. Otdelenov, 等
出版事項: (2020-10-01)

Use of etiotropic and pathogenetic medicines for COVID-19 in patients with renal failure and/or on dialysis
著者:: V. M. Tsvetov, 等
出版事項: (2020-10-01)

Current and future use of vitamin D<sub>3</sub> in patients with COVID-19
著者:: I. N. Sychev, 等
出版事項: (2020-10-01)

Dexamethasone use in patients with COVID-19
著者:: V. A. Otdelenov, 等
出版事項: (2020-10-01)

Could canakinumab be used for COVID-19?
著者:: V. A. Otdelenov, 等
出版事項: (2020-10-01)

Current and future use of aminodihydrophthalazindione sodium in patients with COVID-19, including for «cytokine storm» therapy
著者:: V. M. Tsvetov, 等
出版事項: (2020-10-01)

Rationale for use mefloquine for COVID-19 treatment
著者:: V. A. Otdelenov, 等
出版事項: (2020-10-01)

Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention
著者:: K. B. Mirzaev, 等
出版事項: (2020-10-01)

Methylprednisolone in acute respiratory distress-syndrome in COVID-19: rationales for use, optimal dosage regimens, combined use with tocilizumab
著者:: K. B. Mirzaev, 等
出版事項: (2020-10-01)

Current and future use of angiotensin II receptor blockers in patients with COVID-19
著者:: A. V. Matveev, 等
出版事項: (2020-10-01)

Anticoagulant deprescribing algorithm in patients with COVID-19 after hospital discharge
著者:: A. V. Krykov, 等
出版事項: (2020-10-01)

Possibilities for the use of hydroxychloroquine for pre- and postexposure prophylaxis of SARS-CoV-2 infection among exposed contacts and healthcare personnel
著者:: V. A. Otdelenov, 等
出版事項: (2020-10-01)

Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19
著者:: V. A. Otdelenov, 等
出版事項: (2020-10-01)

Adjusting the role of hydroxychloroquine with or without azithromycin in patients with COVID-19
著者:: V. A. Otdelenov, 等
出版事項: (2020-10-01)

Possibility for the use of bromhexine to prevent infection with SARS-CoV-2
著者:: K. A. Zagorodnikova, 等
出版事項: (2020-10-01)

Monitoring of safety using favipiravir: risk management of adverse drug reactions in clinical practice
著者:: Yu. Yu. Kiselev, 等
出版事項: (2020-10-01)

What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed?
著者:: Yu. Yu. Kiselev, 等
出版事項: (2020-10-01)

Can inhalations of hyaluronidase be used in acute respiratory distress-syndrome in patients with COVID-19?
著者:: Yu. Yu. Kiselev, 等
出版事項: (2020-10-01)

FORMATION OF IMMUNITY AGAINST SARS-COV-2 AMONG EMPLOYEES OF A LARGE GENERAL HOSPITAL
著者:: Михаил Исаакович Ликстанов, 等
出版事項: (2021-04-01)

EXPERIENCE IN THE ORGANIZATION OF MEDICAL CARE FOR PATIENTS IN A MULTIDISCIPLINARY HOSPITAL IN THE CONDITIONS OF THE COVID-19 PANDEMIC
著者:: Игорь Вадимович Пачгин, 等
出版事項: (2021-06-01)

Socio-economic burden of COVID-19 in the Russian Federation
著者:: A. S. Kolbin, 等
出版事項: (2020-05-01)

PREPARATION AND FUNCTIONING OF ENGINEERING SYSTEMS IN THE CONDITIONS OF A REPROFILED COVIDATE HOSPITAL
著者:: Михаил Исаакович Ликстанов, 等
出版事項: (2020-09-01)

CHARACTERISTICS OF OLOKIZUMAB PHARMACOKINETICS IN PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19
著者:: E. V. Tavlueva, 等
出版事項: (2022-12-01)

OXYGEN THERAPY MANAGEMENT IN THE TREATMENT OF PATIENTS WITH NEW CORONAVIRUS INFECTION
著者:: Михаил Исаакович Ликстанов, 等
出版事項: (2021-11-01)

Уязвимые группы в чрезвычайных ситуациях: солидарность и доверие государству как основа стратегий мигрантов в России во время пандемии COVID-19
著者:: Анна Леонидовна Рочева, 等
出版事項: (2020-12-01)

Волновая (де)проблематизация: освещение пандемии коронавируса в России на федеральном телеканале
著者:: Анастасия Дмитриевна Казун, 等
出版事項: (2020-12-01)

Damage of the Muscle System in Covid-19
著者:: I. T. Murkamilov, 等
出版事項: (2021-03-01)

АЛТАЙСКИЙ КРАЙ: ПОСЛЕДСТВИЯ ПАНДЕМИИ COVID-19 И НАПРАВЛЕНИЯ ИХ НИВЕЛИРОВАНИЯ
著者:: Александр Яковлевич Троцковский, 等
出版事項: (2021-06-01)

CLINICAL AND PATHOLOGOANATOMIC CHARACTERISTICS OF ADVERSE OUTCOMES OF SARS-COV-2 IN A LEVEL III HOSPITAL
著者:: Михаил Исаакович Ликстанов, 等
出版事項: (2022-03-01)

EXPERIENCE IN ORGANIZING CARE FOR PATIENTS WITH CORONAVIRUS INFECTION IN A REDESIGNED INFECTIOUS DISEASES HOSPITAL
著者:: Михаил Исаакович Ликстанов, 等
出版事項: (2021-04-01)

ORGANIZATION OF "OPEN REANIMATION" IN THE REPROFILED INFECTIOUS HOSPITAL
著者:: Виталий Сергеевич Самоделкин, 等
出版事項: (2021-06-01)